Azenta Receives Full Repayment of $35 Million Vendor Loan from B Medical Systems Sale
Azenta Inc. (Nasdaq: AZTA) has received full repayment of a $35 million secured vendor loan ahead of its maturity date, as part of the previously announced sale of B Medical Systems S.à r.l. to Thelema S.à r.l., which closed on July 1, 2026. Azenta Germany GmbH had provided this term loan under a Vendor Loan Agreement and has now been repaid in full along with accrued interest. With the repayment of the vendor loan, Azenta has collected the entire $63 million purchase price for B Medical Systems, completing its divestiture strategy. Dr. Martin D. Madaus, Interim President and CEO, noted that this transaction supports Azenta's disciplined capital allocation approach by eliminating credit exposure from the deal. Azenta is a global provider of life sciences solutions with operations in North America, Europe, and Asia.
Topics: capital allocation loan repayment M&A